RxDoctor Payments Data

Zuleikha Tyebjee

Family Medicine · Houston, TXNPI 1104351493

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.0% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations.

$1,204in general payments, 2019–2025

Across 67 payments — averaging $17.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$204
  • Novo Nordisk$138
  • Boehringer Ingelheim$125
  • Gilead$113
  • Viiv Healthcare Company$97
  • Merck$87
  • plus $441 from 16 others

What the payments were for

  • Food & beverage$1,19299%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,204 in reported general payments places this provider in the 65th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Atorvastatin Calcium13$346

Paid to pharmacies, not to this prescriber.

Other family medicine in Houston

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →